{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T13:04:49Z","timestamp":1770901489965,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"DOI":"10.1186\/s12959-026-00838-9","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:04:48Z","timestamp":1770897888000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is congenital thrombotic thrombocytopenic purpura a risk factor for ischemic osteonecrosis of the hip joint (Legg-Calv\u00e9-Perthes disease)?"],"prefix":"10.1186","volume":"24","author":[{"given":"Alexander","family":"Laemmle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"L\u00e4mmle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"1","key":"838_CR1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12959-025-00792-y","volume":"23","author":"M Weise","year":"2025","unstructured":"Weise M, Siegemund T, Kloter T, Keller M, Petros S, Pfrepper C. Reduced half-life of Recombinant ADAMTS13 in a patient with cTTP undergoing total hip arthroplasty. Thromb J. 2025;23(1):102.","journal-title":"Thromb J"},{"issue":"10","key":"838_CR2","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.3324\/haematol.2019.216796","volume":"104","author":"HA van Dorland","year":"2019","unstructured":"van Dorland HA, Taleghani MM, Sakai K, Friedman KD, George JN, Hrachovinova I, et al. The international hereditary thrombotic thrombocytopenic purpura registry: key findings at enrollment until 2017. Haematologica. 2019;104(10):2107\u201315.","journal-title":"Haematologica"},{"issue":"1","key":"838_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/jth.13186","volume":"14","author":"AS von Krogh","year":"2016","unstructured":"von Krogh AS, Quist-Paulsen P, Waage A, Langseth OO, Thorstensen K, Brudevold R, et al. High prevalence of hereditary thrombotic thrombocytopenic purpura in central norway: from clinical observation to evidence. J Thromb Haemost. 2016;14(1):73\u201382.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"838_CR4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1538-7836.2008.02846.x","volume":"6","author":"RS Camilleri","year":"2008","unstructured":"Camilleri RS, Cohen H, Mackie IJ, Scully M, Starke RD, Crawley JT, et al. Prevalence of the ADAMTS-13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura. J Thromb Haemost. 2008;6(2):331\u20138.","journal-title":"J Thromb Haemost"},{"issue":"24","key":"838_CR5","doi-asserted-by":"publisher","first-page":"5888","DOI":"10.1182\/blood-2012-02-408914","volume":"119","author":"M Moatti-Cohen","year":"2012","unstructured":"Moatti-Cohen M, Garrec C, Wolf M, Boisseau P, Galicier L, Azoulay E, et al. Unexpected frequency of Upshaw-Schulman syndrome in pregnancy-onset thrombotic thrombocytopenic purpura. Blood. 2012;119(24):5888\u201397.","journal-title":"Blood"},{"issue":"9","key":"838_CR6","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1302\/0301-620X.88B9.17400","volume":"88","author":"O Wiig","year":"2006","unstructured":"Wiig O, Terjesen T, Svenningsen S, Lie SA. The epidemiology and aetiology of perthes\u2019 disease in Norway. A nationwide study of 425 patients. J Bone Joint Surg Br. 2006;88(9):1217\u201323.","journal-title":"J Bone Joint Surg Br"},{"key":"838_CR7","doi-asserted-by":"publisher","first-page":"1514302","DOI":"10.3389\/fphys.2025.1514302","volume":"16","author":"X Zheng","year":"2025","unstructured":"Zheng X, Dong Z, Ding X, Huang Q, Tang S, Zhang Y, et al. Progress in Understanding Legg-Calve-Perthes disease etiology from a molecular and cellular biology perspective. Front Physiol. 2025;16:1514302.","journal-title":"Front Physiol"},{"issue":"17","key":"838_CR8","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1056\/NEJMra1813013","volume":"381","author":"JA Kremer Hovinga","year":"2019","unstructured":"Kremer Hovinga JA, George JN. Hereditary thrombotic thrombocytopenic purpura. N Engl J Med. 2019;381(17):1653\u201362.","journal-title":"N Engl J Med"},{"issue":"16","key":"838_CR9","doi-asserted-by":"publisher","first-page":"4386","DOI":"10.1182\/bloodadvances.2024013421","volume":"8","author":"O Seidizadeh","year":"2024","unstructured":"Seidizadeh O, Cairo A, Mancini I, George JN, Peyvandi F. Global prevalence of hereditary thrombotic thrombocytopenic purpura determined by genetic analysis. Blood Adv. 2024;8(16):4386\u201396.","journal-title":"Blood Adv"},{"issue":"15","key":"838_CR10","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1182\/blood-2018-11-884700","volume":"133","author":"F Alwan","year":"2019","unstructured":"Alwan F, Vendramin C, Liesner R, Clark A, Lester W, Dutt T, et al. Characterization and treatment of congenital thrombotic thrombocytopenic purpura. Blood. 2019;133(15):1644\u201351.","journal-title":"Blood"},{"issue":"23","key":"838_CR11","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1182\/bloodadvances.2019000959","volume":"3","author":"A Borogovac","year":"2019","unstructured":"Borogovac A, George JN. Stroke and myocardial infarction in hereditary thrombotic thrombocytopenic purpura: similarities to sickle cell anemia. Blood Adv. 2019;3(23):3973\u20136.","journal-title":"Blood Adv"},{"issue":"20","key":"838_CR12","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1182\/blood.2025029789","volume":"146","author":"M Stubbs","year":"2025","unstructured":"Stubbs M, Keogh L, Gounder P, Carter M, Lester W, Taylor A, et al. Long-term follow-up outcomes in congenital thrombotic thrombocytopenic purpura. Blood. 2025;146(20):2457\u201363.","journal-title":"Blood"},{"issue":"25","key":"838_CR13","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1182\/blood.2020009801","volume":"137","author":"E Tarasco","year":"2021","unstructured":"Tarasco E, Butikofer L, Friedman KD, George JN, Hrachovinova I, Knobl PN, et al. Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura. Blood. 2021;137(25):3563\u201375.","journal-title":"Blood"},{"issue":"2","key":"838_CR14","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/bjh.17560","volume":"194","author":"K Sakai","year":"2021","unstructured":"Sakai K, Fujimura Y, Miyata T, Isonishi A, Kokame K, Matsumoto M. Current prophylactic plasma infusion protocols do not adequately prevent long-term cumulative organ damage in the Japanese congenital thrombotic thrombocytopenic purpura cohort. Br J Haematol. 2021;194(2):444\u201352.","journal-title":"Br J Haematol"},{"issue":"21","key":"838_CR15","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1182\/bloodadvances.2019000601","volume":"3","author":"Y Fujimura","year":"2019","unstructured":"Fujimura Y, Lammle B, Tanabe S, Sakai K, Kimura T, Kokame K, et al. Patent ductus arteriosus generates neonatal hemolytic jaundice with thrombocytopenia in Upshaw-Schulman syndrome. Blood Adv. 2019;3(21):3191\u20135.","journal-title":"Blood Adv"},{"issue":"6","key":"838_CR16","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1046\/j.1523-1755.63.6s.1.x","volume":"63","author":"K Assink","year":"2003","unstructured":"Assink K, Schiphorst R, Allford S, Karpman D, Etzioni A, Brichard B, et al. Mutation analysis and clinical implications of von Willebrand factor-cleaving protease deficiency. Kidney Int. 2003;63(6):1995\u20139.","journal-title":"Kidney Int"},{"key":"838_CR17","doi-asserted-by":"publisher","first-page":"17020","DOI":"10.1038\/nrdp.2017.20","volume":"3","author":"JA Kremer Hovinga","year":"2017","unstructured":"Kremer Hovinga JA, Coppo P, Lammle B, Moake JL, Miyata T, Vanhoorelbeke K. Thrombotic thrombocytopenic purpura. Nat Rev Dis Primers. 2017;3:17020.","journal-title":"Nat Rev Dis Primers"},{"issue":"25","key":"838_CR18","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1182\/blood-2015-05-643338","volume":"126","author":"MA Sonneveld","year":"2015","unstructured":"Sonneveld MA, de Maat MP, Portegies ML, Kavousi M, Hofman A, Turecek PL, et al. Low ADAMTS13 activity is associated with an increased risk of ischemic stroke. Blood. 2015;126(25):2739\u201346.","journal-title":"Blood"},{"issue":"6","key":"838_CR19","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1182\/blood-2011-09-380618","volume":"119","author":"HM Andersson","year":"2012","unstructured":"Andersson HM, Siegerink B, Luken BM, Crawley JT, Algra A, Lane DA, et al. High VWF, low ADAMTS13, and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women. Blood. 2012;119(6):1555\u201360.","journal-title":"Blood"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-026-00838-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-026-00838-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-026-00838-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T12:04:49Z","timestamp":1770897889000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12959-026-00838-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["838"],"URL":"https:\/\/doi.org\/10.1186\/s12959-026-00838-9","relation":{},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"6 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"23"}}